Table 1 Baseline characteristics of all enrolled patients with locally advanced breast cancer
Characteristic | FEC arm [cases (%)] | PE arm [cases (%)] | P value |
|---|---|---|---|
Total | 151 | 142 | |
Age (years) | 0.430 | ||
≤35 | 5 (3.31) | 8 (5.63) | |
>35 | 146 (96.69) | 134 (94.37) | |
Menopausal status | 0.263 | ||
Premenopausal | 31 (20.53) | 22 (15.49) | |
Postmenopausal | 120 (79.47) | 120 (84.51) | |
Clinical tumor stage | 0.075 | ||
T2 | 106 (70.20) | 86 (60.56) | |
T3 | 43 (28.48) | 52 (36.62) | |
T4 | 2 (1.32) | 4 (2.82) | |
Clinical nodal status | 0.497 | ||
Involved | 130 (86.09) | 126 (88.73) | |
Not involved | 21 (13.91) | 16 (11.27) | |
ER/PR status | 0.533 | ||
Positive | 96 (63.58) | 89 (62.68) | |
Negative | 47 (31.13) | 52 (36.62) | |
Missing | 8 (5.30) | 1 (0.70) | |
HER2 (IHC staining) | 0.189 | ||
0/1+ | 64 (42.38) | 66 (46.48) | |
2+ | 31 (20.53) | 26 (18.31) | |
3+ | 45 (29.80) | 47 (33.10) | |
Missing | 11 (7.28) | 3 (2.11) | |